Grant Recipients

John Carter, MD, PhD

Fred Hutchinson Cancer Research Center at Seattle Children's Hospital

Identification of novel cdk4/6 effectors in T cell acute lymphoblastic leukemia

Gregory Owens, PhD

University of Colorado School of Medicine

Targets of the Intrathecal B-Cell Response in Pediatric Opsoclonus-Myoclonus Syndrome

Bethan Lang, MD

Oxford University

Detection of novel autoantibodies in children with OMS

Ying Zhang, PhD

Mayo Clinic

The role of the de-ubiquitinase USP44 in childhood germ cell tumorigenesis

Shilpa Pathak, PhD

Roswell Park Cancer Institute

Development of anti-tumor molecules targeting the Wilms tumor oncogene, LIN28B

Shizen Zhu, MD, PhD

Dana-Farber Cancer Institute

Role of the GAB2-SHP2 network in childhood neuroblastoma pathogenesis

Monica Thakar, MD

Children's Hospital of Wisconsin, Medical College of Wisconsin

A Phase I/II Trial Evaluating NK Cell Immunotherapy in Relapsed and Refractory Pediatric Solid Tumors

Boris Wilson, PhD

Dana-Farber Cancer Institute

Elucidating epigenetic mechanisms for therapeutic targeting in aggressive pediatric cancers

Chungling Yi, PhD

Lombardi Cancer Center at Georgetown University

Develop Small Molecule Yap Inhibitors to Treat Childhood Cancer

Elizabeth Mullen, MD

Dana-Farber Cancer Institute

Identification of Clinical Biomarkers of Wilms Tumor Using High Accuracy Mass Spectroscopy Urine Proteome Profiling

Holly Meany, MD

Children's National Medical Center

Phase I Dose Escalation Study of Sorafenib/Irinotecan Combination Therapy in Pediatric Relapsed Solid Tumors

Loretta Lau, MD

The Children's Hospital at Westmead

Alternative Lengthening of Telomeres in Neuroblastoma

Austin Brown, PhD

Baylor College of Medicine, Houston TX

Genetic Determinants of Neuropsychological Performance Following Treatment for Pediatric Embryonal Brain Tumors

Theodore Nicolaides, MD

New York University

Dr. Muller Fabbri, MD, PhD

University of Hawaii

Kevin Jones, MD

University of Utah

Role of MITF in Clear Cell Sarcomagenesis

Kira Bona, MD, MPH

Dana-Farber Cancer Institute, Harvard

Development of a Material Hardship Intervention

Prof. Dr. Franz Blaes

Justus-Liebig-University, Germany

Modification of onconeuronal antigens in the neuroblastoma of paraneoplastic OMS by free RNA